Recent news on Sumatriptan Succinate

Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy ...  -  May 2, 2007
PR Newswire (press release),About Imitrex(R) (sumatriptan succinate) Tablets Imitrex is a prescription medication indicated for the acute treatment of migraine in adults.

Trexima(TM) (Sumatriptan/Naproxen Sodium) Superior Efficacy Data ...  -  Apr 3, 2007
PR Newswire (press release),About Imitrex(R) (sumatriptan succinate) Tablets Imitrex is a prescription medication indicated for the acute treatment of migraine in adults.

Sumatriptan–Naproxen Combo for Migraine  -  Apr 6, 2007
Medscape (subscription)The purpose of the 2 studies reported here was to evaluate the safety and efficacy of a fixed-dose tablet containing 85 mg of sumatriptan succinate and 500

Sumatriptan-Naproxen for Acute Treatment of Migraine A Randomized ...  -  Apr 3, 2007
Journal of American Medical Association (subscription),Objective To evaluate the efficacy and safety of a fixed-dose tablet containing sumatriptan succinate and naproxen sodium relative to efficacy and safety of

Pozen's Trexima Begins Six Month FDA Review  -  Apr 10, 2007
Seeking Alpha,Trexima is a single tablet containing sumatriptan succinate (Imitrex, also sold by GSK) and naproxen sodium (contained in Aleve amongst other non-steroidal

Pozen Announces Trexima (Sumatriptan Succinate and Naproxen Sodium ...  -  Mar 23, 2007
PharmaLive.com (press release),Trexima is the proposed brand name for the combination of sumatriptan succinate, formulated with RT Technology(TM), and naproxen sodium, in a single tablet

FDA Approves To Review Amended Response Of Pozen's Trexima - Update  -  Mar 22, 2007
Trading Markets,The company noted that Trexima is the proposed brand name for the combination of sumatriptan succinate, formulated with RT Technology and naproxen sodium,

Pozen: On Track With New Pain Medications  -  Mar 12, 2007
Seeking Alpha,Trexima is a single pill containing 85mg sumatriptan succinate (Glaxo's Imitrex) and 500mg naproxen sodium (sold over-the-counter as Aleve, by Bayer).

Spectrum Pharmaceuticals, Inc. Announces Financial Update and ...  -  Mar 14, 2007
PR-Inside.com (Pressemitteilung),...and Generics - ANDA for sumatriptan succinate injection approved tentatively by FDA - Received $5 million payment from Par Pharmaceutical Companies,

Breather for local pharma majors in sight  -  Mar 16, 2007
Daily News & Analysis,Reddy’s, which settled a spat with GlaxoSmithKline over migraine drug Imitrex (sumatriptan succinate), will exclusively distribute an authorised generic

SMS Pharmaceuticals ends below issue price  -  Feb 28, 2007
Moneycontrol.com,It is mainly engaged in manufacturing bulk drugs like Ranitidine HCl, Sumatriptan Succinate, Sildenafil Citrate, Omeprazole pellets, Ramipril,

Angel Broking neutral on SMS Pharma IPO  -  Feb 5, 2007
Moneycontrol.com,The company has developed a non-infringing process for Sumatriptan Succinate, for which it has tied up with Ranbaxy, which has filed for a Para-IV filing

SMS Pharma to invest Rs 1130.20 mn for expansion  -  Feb 8, 2007
Myiris.com,It is mainly engaged in manufacturing bulk drugs like Ranitidine HCl, Sumatriptan Succinate, Sildenafil Citrate, Omeprazole Magnesium, Ramipril,

Teva Announces Tentative Approval Of Sumatriptan Succinate Tablets  -  Nov 30, 2006
PipelineReview.com (press release),Upon final approval, Teva's Sumatriptan Succinate Tablets will be the AB-rated generic equivalent of GlaxoSmithKline's Imitrex® Tablets, indicated for acute

Teva Pharmaceutical (TEVA) Granted Tentative Approval of ...  -  Nov 29, 2006
StreetInsider.com (subscription),Teva's Sumatriptan Succinate Tablets will be the AB-rated generic equivalent of GlaxoSmithKline's Imitrex Tablets, indicated for acute treatment of migraine

Teva Gets Tentative FDA OK Of Sumatriptan Succinate Tablets  -  Nov 29, 2006
Therapeutics Daily (subscription) (press release),Teva's sumatriptan succinate tablets are the generic equivalent of GlaxoSmithKline PLC's (GSK) Imitrex tablets, indicated for acute treatment of migraine

Market Report -- In Play (TEVA)  -  Nov 29, 2006
MSN MoneyTeva Pharm announces tentative approval of Sumatriptan Succinate tablets Co announces that the FDA has granted tentative approval for the co's Abbreviated

Teva gets tentative ok for generic migraine drug  -  Nov 29, 2006
ReutersO: Quote, Profile, Research) said on Wednesday the US Food and Drug Administration has granted tentative approval for the company's sumatriptan succinate

Teva Pharmaceutical Posted Modest Gains After Winning Tentative ...  -  Nov 29, 2006
Trading Markets,Teva's Sumatriptan Succinate Tablets are indicated for treatment of migraine headaches. Teva Pharmaceutical gapped up Wednesday but gave back some of its

Teva Pharmaceutical Industries Wins Tentative Approval Of Migraine ...  -  Nov 29, 2006
Trading Markets,Teva's Sumatriptan Succinate Tablets are indicated for treatment of migraine headaches. Teva Pharmaceutical Industries traded lower for the majority of the

Generic Imitrex Tentatively Cleared  -  Nov 29, 2006
TheStreet.comTeva's version of the drug, also known as sumatriptan succinate, is expected to receive final approval in February 2009, after Glaxo's patent on the drug

Teva Gets Tentative Generic Imitrex OK  -  Nov 29, 2006
Houston Chronicle,The tentative approval covers 25-milligram, 50-milligram and 100-milligram strength tablets of sumatriptan succinate, the active ingredient in Imitrex.

Teva wins tentative approval for generic Glaxo migraine drug  -  Nov 29, 2006
Forbes,...granted tentative approval for the company's Abbreviated New Drug Application (ANDA) for sumatriptan succinate tablets in 25 mg, 50 mg and 100 mg does.

Teva gets FDA approval for generic Imitrex  -  Nov 29, 2006
Globes,The company today announced that the US Food and Drug Administration (FDA) has granted it conditional approval to market Sumatriptan Succinate pills for

Teva: GSK's latest headache  -  Nov 30, 2006
Pharmaceutical Business Review...'Content Teva's tentatively approved application for sumatriptan succinate includes tablets of 25mg, 50mg and 100mg, and the Israeli drug maker anticipates

Pharma Sector: Few Newsmakers Of The Week - Teva, Barr, Genta ...  -  Dec 1, 2006
Trading Markets,...(TEVA | charts | news | PowerRating) Abbreviated New Drug Application for Sumatriptan Succinate Tablets indicated for the treatment of migraine.

The Holidays Can Be A Headache for Millions of Americans But for ...  -  Dec 5, 2006
Drug Newswire (press release),..."If you are diagnosed with migraines, your doctor may prescribe a migraine-specific medication, like Imitrex(R) (sumatriptan succinate) Tablets,

The Holidays Can Be A Headache for Millions of Americans But for ...  -  Dec 5, 2006
Yahoo! News (press release)..."If you are diagnosed with migraines, your doctor may prescribe a migraine-specific medication, like Imitrex® (sumatriptan succinate) Tablets, to help treat

GDP Report Suggesting Strong Growth May Lift Stocks; Housing Data ...  -  Nov 29, 2006
Trading Markets,...to its announcement that it has received tentative approval for its ANDA for Sumatriptan Succinate tablets of 25 mg, 50 mg and 100 mg formulations.

Teva Announces Tentative Approval Of Sumatriptan Succinate Tablets  -  Dec 1, 2006
Medical News Today (press release),US Food and Drug Administration has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Sumatriptan Succinate Tablets, 25 ...

Teva Pharmaceutical (TEVA) Granted Tentative Approval of ...  -  Nov 29, 2006
StreetInsider.com (subscription),...(Nasdaq: TEVA) said the FDA has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Sumatriptan Succinate Tablets, 25 mg ...

Teva Gets Tentative FDA OK Of Sumatriptan Succinate Tablets  -  Nov 29, 2006
Therapeutics Daily (subscription) (press release),...said the Food and Drug Administration has granted tentative approval for the company's abbreviated new drug application for sumatriptan succinate tablets in 25 ...

Market Report -- In Play (TEVA)  -  Nov 29, 2006
MSN MoneyTeva Pharm announces tentative approval of Sumatriptan Succinate tablets Co announces that the FDA has granted tentative approval for the co's Abbreviated New ...

Teva Pharmaceutical Industries Wins Tentative Approval Of Migraine ...  -  Nov 29, 2006
Trading Markets,...that the US Food and Drug Administration has granted tentative approval for its Abbreviated New Drug Application or ANDA for Sumatriptan Succinate Tablets, 25 ...

Teva gets FDA approval for generic Imitrex  -  Nov 29, 2006
Globes,The company today announced that the US Food and Drug Administration (FDA) has granted it conditional approval to market Sumatriptan Succinate pills for severe ...

Pharma Sector: Few Newsmakers Of The Week - Teva, Barr, Genta ...  -  Dec 1, 2006
Trading Markets,Teva Pharmaceutical Industries Ltd.'s. (TEVA | charts | news | PowerRating) Abbreviated New Drug Application for Sumatriptan Succinate Tablets indicated for ...

Teva: GSK's latest headache  -  Nov 30, 2006
Pharmaceutical Business Review...'Content Teva's tentatively approved application for sumatriptan succinate includes tablets of 25mg, 50mg and 100mg, and the Israeli drug maker anticipates ...

Teva gets tentative ok for generic migraine drug  -  Nov 29, 2006
ReutersProfile, Research) said on Wednesday the US Food and Drug Administration has granted tentative approval for the company's sumatriptan succinate tablets in 25 mg ...

The Holidays Can Be A Headache for Millions of Americans But for ...  -  Dec 5, 2006
Yahoo! News (press release)..."If you are diagnosed with migraines, your doctor may prescribe a migraine-specific medication, like Imitrex® (sumatriptan succinate) Tablets, to help treat ...

Teva gets tentative generic Imitrex OK  -  Nov 29, 2006
BusinessWeekThe tentative approval covers 25-milligram, 50-milligram and 100-milligram strength tablets of sumatriptan succinate, the active ingredient in Imitrex. ...

Generic Imitrex Tentatively Cleared  -  Nov 29, 2006
TheStreet.comTeva's version of the drug, also known as sumatriptan succinate, is expected to receive final approval in February 2009, after Glaxo's patent on the drug ...

GDP Report Suggesting Strong Growth May Lift Stocks; Housing Data ...  -  Nov 29, 2006
Trading Markets,...charts | news | PowerRating) is likely to react to its announcement that it has received tentative approval for its ANDA for Sumatriptan Succinate tablets of ...

Cobalt settles Imitrex litigation with Glaxo  -  Nov 15, 2006
Pharmaceutical Business ReviewCobalt Laboratories has settled patent litigation with GlaxoSmithKline relating to sumatriptan succinate tablets, the generic version of GSK's Imitrex tablets. ...

Dr Reddy's announces settlement of Imitrex litigation  -  Nov 17, 2006
Moneycontrol.com (press release),Dr. Reddy’s Laboratories (NYSE:RDY) announced today that it has settled patent litigation with GlaxoSmithKline relating to sumatriptan succinate tablets, the ...

Cobalt Announces Settlement of Imitrex(R) Litigation With ...  -  Nov 15, 2006
Yahoo! News (press release)Cobalt Pharmaceuticals Inc., announced today that is has settled patent litigation with GlaxoSmithKline relating to sumatriptan succinate tablets, the generic ...

Spectrum Filed ANDA with Paragraph IV Certification for ...  -  Nov 14, 2006
ag-IP-news Agency,GlaxoSmithKline's Imitrex Injection (sumatriptan succinate injection) for the acute treatment of migraine attacks and the acute treatment of cluster headache ...

Par Pharmaceutical Announces Agreement With GSK to Settle Imitrex ...  -  Nov 13, 2006
Pharmaceutical Processing,Imitrex Injection (sumatriptan succinate injection) is used for the acute treatment of migraine attacks with or without aura, and the acute treatment of ...

Cobalt says reaches patent settlement with GlaxoSmithKline  -  Nov 15, 2006
Reuters...said it reached a patent litigation settlement with GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) regarding sumatriptan succinate tablets, the generic ...

Cobalt Labs Settles With GlaxoSmithKline  -  Nov 15, 2006
Houston Chronicle,The settlement, which still must pass Federal Trade Commission review, allows Cobalt to begin selling tablets of sumatriptan succinate, the active ingredient ...

Glaxo and Spectrum settle drug patent suit  -  Nov 14, 2006
Los Angeles Times,Under a separate agreement with Par Pharmaceutical Cos., Spectrum will get most of the profit from sales of sumatriptan succinate, the generic name for Imitrex ...

Spectrum Pharmaceuticals says settled Imitrex patent litigation ...  -  Nov 13, 2006
Euro2day,GlaxoSmithKline''s Imitrex Injection (sumatriptan succinate injection) for the acute treatment of migraine attacks and the acute treatment of cluster headache ...

JJYeley: Home Away from Home  Aug 2, 2006
18 Imitrex (sumatriptan succinate) Chevrolet for Joe Gibbs Racing came to NASCAR by way of the Indianapolis-based United States Auto Club (USAC). ... -WhoWon.com

JJ Yeley- home away from home  Aug 2, 2006
18 ImitrexR (sumatriptan succinate) Chevrolet for Joe Gibbs Racing came to NASCAR by way of the Indianapolis-based United States Auto Club (USAC). ... -Racing Milestones

Series: NASCAR NEXTEL Cup Series  Aug 6, 2006
18 Imitrex® (sumatriptan succinate) Chevrolet, finished a disappointing 34th after holding steady in either the 10th or 11th spot for much of the day. ... -Joe Gibbs Racing

Indianapolis: JJ Yeley race report  Aug 6, 2006
160-lap race sent Yeley's No. 18 Imitrex® (sumatriptan succinate) Chevrolet sideways into the wall. Yeley finished on the lead ... -Motorsport.com

JGR Lineup: JJ Yeley (6th), Denny Hamlin (14th), Tony Stewart ...  Aug 5, 2006
18 Imitrex® (sumatriptan succinate) Chevrolet, qualified sixth to lead the three-car contingent of Joe Gibbs Racing in time trials for Sunday's Allstate 400 ... -Joe Gibbs Racing

Pozen to Submit Full Response to Trexima Approvable Letter During ...  Jul 31, 2006
Trexima is the proposed brand name for the combination of sumatriptan succinate, formulated with RT Technology(TM), and naproxen sodium, in a single tablet for ... -PharmaLive.com

POZEN (POZN) to Submit Full Response to Trexima Approvable Letter ...  Jul 31, 2006
Trexima is the proposed brand name for the combination of sumatriptan succinate, formulated with RT Technology, and naproxen sodium, in a single tablet for the ... -StreetInsider.com (subscription)

New Data Demonstrate Sustained Efficacy of Single Tablet ...  Jun 26, 2006
...currently under review by the United States Food and Drug Administration (FDA) under the proposed trade name Trexima(TM) (sumatriptan succinate/naproxen sodium ... -PR Newswire

New Data Show Investigational Migraine Therapy Demonstrates ...  Jun 26, 2006
About Imitrex(R) (sumatriptan succinate) Tablets Imitrex is a prescription medication indicated for the acute treatment of migraine in adults. ... -PR Newswire



Spectrum Pharmaceuticals Reports First Quarter 2006 Financial ...  May 8, 2006
...a strategic alliance with Par Pharmaceuticals to distribute our generic products, including, once approved by the FDA, sumatriptan succinate injection, the ... - PR Newswire





New Pivotal Trial Data Demonstrated Superior Clinical Benefits of ...  Apr 5, 2006
...currently under review by the United States Food and Drug Administration under the proposed trade name Trexima(TM) (sumatriptan succinate/naproxen sodium). ... - PR Newswire

Spectrum Pharmaceuticals Announces Filing of Thirteenth ANDA, for ...  Mar 13, 2006
...currently has nine other ANDAs that are under review at the FDA, including an ANDA with Paragraph IV certification for sumatriptan succinate injection, the ... - PR Newswire

Spectrum Pharmaceuticals Reports 2005 Financial Results and ...  Mar 15, 2006
...made a strategic alliance with PAR Pharmaceuticals to distribute our generic products, when approved by the FDA, including sumatriptan succinate injection, the ... - PR Newswire

Spectrum Pharma Files ANDA For Injectable Drug With FDA - Quick ...  Mar 13, 2006
...charts | news | Powerrating) that are under review at the FDA, including an ANDA with Paragraph IV certification for sumatriptan succinate injection, the ... - Trading Markets

Caretek Medical announces Lead Drug Candidate for ImplaJect ...  Mar 9, 2006
...based company developing an innovative needle-free drug delivery system known as ImplaJect(r), today announced the selection of Sumatriptan Succinate as its ... - PharmaLive.com



FDA Approves New Formulation of Imitrex (Sumatriptan Succinate) ...  Feb 2, 2006
NC -- February 2, 2006 -- The United States Food and Drug Administration (FDA) has approved a new formulation of Imitrex (sumatriptan succinate) Injection that ... - DG News

FDA Approves New Formulation of Imitrex(R) (Sumatriptan Succinate) ...  Feb 2, 2006
RESEARCH TRIANGLE PARK, NC, Feb. 2 /PRNewswire/ -- The United States Food and Drug Administration (FDA) has approved a new formulation ... - Yahoo! News

Par Pharmaceutical Announces Product Collaboration with Spectrum ...  Feb 23, 2006
Among the products included in the agreement is sumatriptan succinate injection 6 mg/0.5 mL, the generic version of GlaxoSmithKline's (GSK) Imitrex(R) Injection ... - PR Newswire,

FDA Approves New Formulation of Imitrex (Sumatriptan Succinate) ...  Feb 2, 2006
NC -- February 2, 2006 -- The United States Food and Drug Administration (FDA) has approved a new formulation of Imitrex (sumatriptan succinate) Injection that ... - DG News

Migraine - FDA Approves New Formulation Of Imitrex® (sumatriptan ...  Feb 5, 2006
Patients Can Now Take a 4mg Dose Using the Convenient Imitrex STATdose System ®; Imitrex Injection Offers Fast Relief for Migraine, Starts Working As Early As ... - Medical News Today

FDA Approves New Formulation of Imitrex (Sumatriptan Succinate) ...  Feb 2, 2006
RESEARCH TRIANGLE PARK, NC, February 02, 2006 /PRNewswire/ -- The United States Food and Drug Administration (FDA) has approved a new formulation of Imitrex ... - PharmaLive.com

FDA Approves New Formulation of Imitrex(R) (Sumatriptan Succinate) ...  Feb 2, 2006
RESEARCH TRIANGLE PARK, NC, Feb. 2 /PRNewswire/ -- The United States Food and Drug Administration (FDA) has approved a new formulation ... - Yahoo! News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional